A review of the potential mechanisms of action of baclofen in alcohol use disorder

R De Beaurepaire - Frontiers in Psychiatry, 2018 - frontiersin.org
Baclofen, a GABA-B receptor agonist, is a promising treatment for alcohol use disorder
(AUD). Its mechanism of action in this condition is unknown. GABA-B receptors interact with …

Safety and efficacy of baclofen in the treatment of alcohol-dependent patients

G Addolorato, L Leggio - Current pharmaceutical design, 2010 - ingentaconnect.com
Preclinical studies show that antagonism of the GABAB receptor may represent an effective
neuropharmacological approach to treat alcohol dependence. Consistent with preclinical …

A deeper insight into how GABA-B receptor agonism via baclofen may affect alcohol seeking and consumption: lessons learned from a human laboratory investigation

M Farokhnia, SL Deschaine, A Sadighi… - Molecular …, 2021 - nature.com
Previous studies suggest that GABA-B receptor agonism may represent an effective
pharmacological approach to treat addictive disorders. Baclofen is a selective GABA-B …

Effectiveness and safety of baclofen in the treatment of alcohol dependent patients

L Leggio, JC Garbutt… - CNS & Neurological …, 2010 - ingentaconnect.com
Both preclinical and clinical research studies have shown the GABAB receptor agonist
baclofen represents a promising treatment for alcohol dependence. Preliminary clinical …

Using baclofen to explore GABA-B receptor function in alcohol dependence: insights from pharmacokinetic and pharmacodynamic measures

CF Durant, LM Paterson, S Turton, SJ Wilson… - Frontiers in …, 2018 - frontiersin.org
Background: The role of GABA-B neurotransmission in addiction has recently received
increased attention, with clinical trials indicating that baclofen, a GABA-B receptor agonist …

GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence

R Agabio, G Colombo - Frontiers in neuroscience, 2014 - frontiersin.org
The present paper summarizes the preclinical and clinical studies conducted to define the
“anti-alcohol” pharmacological profile of the prototypic GABAB receptor agonist, baclofen …

Targeting the GABAB Receptor for the Treatment of Alcohol Use Disorder

R Agabio, KA Leite-Morris, G Addolorato, G Colombo - GABAB receptor, 2016 - Springer
Accumulating lines of experimental and clinical evidence suggest that the prototypic,
orthosteric GABA type B (GABA B) receptor agonist, baclofen, may possess therapeutic …

GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators

R Agabio, G Colombo - Psychiatria Polska, 2015 - iris.unica.it
The present paper summarizes experimental and clinical data indicating the therapeutic
potential of the GABAB receptor agonist, baclofen, in the treatment of alcohol use disorder …

Baclofen in the treatment of patients with alcohol use disorder and other mental health disorders

R Agabio, L Leggio - Frontiers in Psychiatry, 2018 - frontiersin.org
A limited number of medications are approved to treat Alcohol Use Disorder (AUD).
Furthermore, the magnitude of their therapeutic effect is relatively modest, suggesting the …

Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates

MA Gorsane, O Kebir, G Hache, L Blecha… - Substance …, 2012 - journals.sagepub.com
Baclofen, a γ-aminobutyric acid (GABA)-B receptor agonist, represents a promising drug in
alcohol addiction management. Animal models have shown its action at various stages of …